TRIPODI FARIDA

Secchi, V., Armanni, A., Barbieri, L., Bruno, A., Colombo, A., Fumagalli, S., et al. (2025). Advanced techniques and nanotechnologies for point-of-care testing. FRONTIERS IN NANOTECHNOLOGY, 6 [10.3389/fnano.2024.1465429]. Dettaglio

Lambiase, A., Spandri, G., Moukham, H., Toini, E., D’Urzo, A., Zecca, G., et al. (2025). Acteoside exerts neuroprotective effects by preventing α-synuclein aggregation and oxidative stress in models of Parkinson's disease. NEUROTHERAPEUTICS [10.1016/j.neurot.2025.e00825]. Dettaglio

Lambiase, A., Moukham, H., Spandri, G., Solana-Manrique, C., Paricio, N., Tripodi, F., et al. (2025). Neuroprotective effects of verbascoside on eukaryotic models of Parkinson’s disease. Intervento presentato a: PhD day 2025, Padova, Italia. Dettaglio

Moukham, H., Galli, F., Spandri, G., Lambiase, A., Serio, S., Santoro, V., et al. (2025). Glabranin as a natural modulator of AMPK signaling and lipid metabolism in non-alcoholic fatty liver disease. Intervento presentato a: Forum Nazionale della Biodiversità 2025, Milano, Italia. Dettaglio

Moukham, H., Spandri, G., Lambiase, A., Serio, S., Santoro, V., Piccinelli, A., et al. (2025). Targeting NAFLD via AMPK activation and Lipid droplet clearance: The Role of natural bioactive compounds. Intervento presentato a: SIB "Nutrition and Environment" and "Membrane", Bologna, Italia. Dettaglio